Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease-Reference-Cited by-同舟云学术

Canadian Association of Gastroenterology Clinical Practice Guidelines: The Use of Infliximab in Crohn's Disease

Published:2004 Issue:8 Volume:18 Page:503-508
ISSN:0835-7900
Container-title:Canadian Journal of Gastroenterology
language:en
Short-container-title:Canadian Journal of Gastroenterology

Author:

Panaccione Remo¹,Fedorak Richard N²,Anmais Guy³,Bernstein Charles N⁴,Bitton Alain⁵,Croitoru Ken⁶,Enns Robert⁷,Feagan Brian⁸,Fishman Marty⁷,Greenberg Gordon⁹,Griffiths Anne⁹,Marshall John K⁶,Rasul Imran¹⁰,Sadowski Daniel²,Seidman Ernest¹¹,Steinhart Hillary⁹,Sutherland Lloyd¹,Walli Eric¹²,Wild Gary⁵,Williams C Noel²,Zachos Mary⁹

Affiliation:

1. University of Calgary, Calgary, Alberta, Canada

2. University of Alberta, Edmonton, Alberta, Canada

3. Hôpital Maisonneuve-Rosemont, Montreal, Quebec, Canada

4. University of Manitoba, Winnipeg, Manitoba, Canada

5. McGill University, Montreal, Quebec, Canada

6. McMaster University, Hamilton, Ontario, Canada

7. University of British Columbia, Vancouver, British Columbia, Canada

8. University of Western Ontario, London, Ontario, Canada

9. University of Toronto, Toronto, Ontario, Canada

10. Credit Valley Hospital, Mississauga, Ontario, Canada

11. St Justine Hospital, Montreal, Quebec, Canada

12. Winnipeg Clinic, Winnipeg, Manitoba, Canada

Abstract

These guidelines are presented as a follow-up to the original Canadian Association of Gastroenterology Clinical Practice Guidelines: The use of infliximab in Crohn's disease, published in the Canadian Journal of Gastroenterology (1). The original guidelines represented publications between 1998 and 2000. The current guidelines have been updated to reflect knowledge gained from two pivotal randomized clinical trails, with the use of infliximab in the maintenance of inflammatory Crohn's disease in remission (2) and in the maintenance of fistulous Crohn's disease in remission (3).

Funder

Schering Canada Inc.

Publisher

Hindawi Limited

Subject

Gastroenterology,General Medicine

Link

http://downloads.hindawi.com/journals/cjgh/2004/670161.pdf

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic Evaluations of Treatments for Inflammatory Bowel Diseases: A Literature Review;Canadian Journal of Gastroenterology and Hepatology;2018-06-13

2. Mortality Trends in Crohnʼs Disease and Ulcerative Colitis;Inflammatory Bowel Diseases;2016-02

3. Step Up Versus Early Biologic Therapy for Crohnʼs Disease in Clinical Practice;Inflammatory Bowel Diseases;2013-06

4. Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines;Alimentary Pharmacology & Therapeutics;2013-04-02

5. Use of the tumor necrosis factor-blockers for Crohn's disease;World Journal of Gastroenterology;2012